Steven W. Papish

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer

Julie R. Nangia, Tao Wang, Cynthia Osborne et al. · JAMA · 2017 · 229 citations

Medicine, Dermatology, Oncology +13

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

John P. Leonard, Kathryn S. Kolibaba, James A. Reeves et al. · Journal of Clinical Oncology · 2017 · 189 citations

Medicine, Hematology, Oncology +17

COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma.

D. Barry Boyd, Morton Coleman, Steven W. Papish et al. · Journal of Clinical Oncology · 1988 · 84 citations

Medicine, Oncology, Pharmacology +14

Assessment of Left Ventricular Contractility in Patients Receiving Doxorubicin

Kenneth M. Borow, I. Craig Henderson, Alexander Neuman et al. · Annals of Internal Medicine · 1983 · 55 citations

Medicine, Cardiology, Pharmacology +13